Lupus Anticoagulant Abs Test at Ayzal Lab

Lupus Anticoagulant Abs at Ayzal Lab

The Lupus Anticoagulant Antibodies (Lupus Anticoagulant Abs) test is a highly specialized hematological and immunological laboratory investigation performed at Ayzal Lab. Despite its misleading name, the lupus anticoagulant is an antibody that actually increases the risk of blood clots (thrombosis) in both veins and arteries, rather than acting as an anticoagulant in the living body. This test is a critical component of the diagnostic workup for antiphospholipid syndrome (APS), an autoimmune disorder characterized by recurrent thrombosis and pregnancy complications, including unexplained miscarriages. At Ayzal Lab, we utilize advanced automated coagulation analyzers to perform a series of phospholipid-dependent clotting assays, ensuring precise, reproducible, and clinically actionable results for patients and referring physicians.

Understanding the clinical significance of Lupus Anticoagulant Abs is essential for managing thrombotic risks. These antibodies are directed against negatively charged phospholipids and phospholipid-binding proteins, such as beta-2 glycoprotein I and prothrombin, which are located on cell membranes. In vitro (in the laboratory test tube), these antibodies interfere with the phospholipid complexes required for the coagulation cascade, thereby prolonging clotting times. However, in vivo (inside the patient’s body), they promote platelet activation and endothelial cell dysfunction, leading to a hypercoagulable state. By conducting this test, Ayzal Lab helps clinicians identify the underlying cause of unexplained prolonged Activated Partial Thromboplastin Time (aPTT), evaluate patients with a history of thromboembolism, and investigate obstetric complications.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of diagnostic accuracy and prevent pre-analytical errors, patients must adhere to specific preparation guidelines before undergoing the Lupus Anticoagulant Abs test at Ayzal Lab:

• Medication Review: It is critical to inform your prescribing physician and the laboratory staff about all medications you are currently taking. Anticoagulant therapies, including heparin, low-molecular-weight heparin (LMWH), warfarin, and direct oral anticoagulants (DOACs) like rivaroxaban or apixaban, can significantly interfere with the test results, leading to false-positive or false-negative outcomes.
• Timing of the Test: Ideally, this test should be performed when the patient is not actively undergoing anticoagulant therapy. If a patient is on warfarin, the test is typically delayed until the therapy has been discontinued for at least 1 to 2 weeks, or bridging therapy is managed under strict medical supervision. For heparin, the test should be performed at least 12 to 24 hours after the last dose.
• Fasting Requirements: While strict fasting is not universally mandatory for this specific assay, a light fasting period of 4 to 6 hours is recommended to minimize lipemia (excess fat in the blood), which can interfere with optical coagulation detection systems.
• Hydration: Adequate hydration with plain water is encouraged to facilitate easier venous access during the blood draw.
• Avoid Stress and Vigorous Exercise: Physical exertion and acute stress can temporarily alter coagulation factor levels; patients should remain calm and rested prior to sample collection.

During the Procedure

The Lupus Anticoagulant Abs test requires a standard venipuncture to collect a blood sample. At Ayzal Lab, our trained phlebotomists follow strict protocols to ensure patient comfort and sample integrity:

• Patient Positioning: The patient is comfortably seated in a specialized phlebotomy chair. The arm is extended and supported to identify a suitable vein, typically in the antecubital fossa (the crook of the elbow).
• Aseptic Technique: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry to prevent contamination.
• Sample Collection: A tourniquet is applied briefly above the puncture site to increase venous pressure. A sterile, single-use needle is inserted into the vein, and blood is drawn into a sodium citrate tube (light blue top). The ratio of blood to anticoagulant in the tube must be precisely 9:1 to ensure valid coagulation testing.
• Post-Collection Care: Once the tube is filled to the correct volume, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze to prevent hematoma formation. A small bandage is then applied.
• Sample Processing: The sodium citrate tube is immediately inverted gently 3 to 4 times to mix the blood with the anticoagulant. It is then transported to the laboratory where it undergoes double centrifugation (platelet-poor plasma preparation) within a strictly controlled timeframe to ensure that platelets, which contain phospholipids, do not interfere with the assay.

When is a Lupus Anticoagulant Abs Test Performed?

Investigation of Unexplained Blood Clots

Physicians request the Lupus Anticoagulant Abs test when a patient presents with one or more episodes of unexplained venous or arterial thrombosis. This includes deep vein thrombosis (DVT) in the legs, pulmonary embolism (PE) in the lungs, or arterial clots leading to premature stroke or myocardial infarction (heart attack) in young individuals without traditional cardiovascular risk factors. Identifying the presence of these antibodies helps determine the duration and intensity of long-term anticoagulation therapy.

Evaluation of Recurrent Pregnancy Loss

Obstetricians routinely order this test as part of a comprehensive workup for recurrent pregnancy loss. Clinical indications include three or more consecutive unexplained spontaneous abortions before the 10th week of gestation, one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week, or one or more premature births before the 34th week due to severe preeclampsia, eclampsia, or placental insufficiency. Detecting lupus anticoagulant allows for targeted therapeutic interventions, such as low-dose aspirin and heparin, to improve pregnancy outcomes.

Investigating an Isolated Prolonged aPTT

An isolated, unexplained prolongation of the Activated Partial Thromboplastin Time (aPTT) discovered during routine pre-operative screening or general health checks is a primary indication for this test. If the aPTT remains prolonged even after mixing the patient’s plasma with normal pooled plasma (a mixing study), it strongly suggests the presence of an inhibitor like lupus anticoagulant rather than a clotting factor deficiency. The Lupus Anticoagulant Abs panel is then performed to confirm this suspicion.

Diagnosis of Antiphospholipid Syndrome (APS)

The Lupus Anticoagulant Abs test is one of the three laboratory criteria required for the diagnosis of Antiphospholipid Syndrome (APS), alongside anti-cardiolipin antibodies and anti-beta-2 glycoprotein I antibodies. To establish a formal diagnosis of APS, the test must yield positive results on two or more occasions at least 12 weeks apart. This persistence distinguishes transient antibodies, which may arise during acute infections, from chronic autoimmune-mediated antibodies.

Monitoring Patients with Systemic Lupus Erythematosus (SLE)

Patients diagnosed with Systemic Lupus Erythematosus (SLE) or other systemic autoimmune connective tissue diseases are frequently screened for lupus anticoagulant. Approximately 10% to 30% of patients with SLE test positive for these antibodies. Knowing a patient’s lupus anticoagulant status is vital for risk stratification, as those who test positive have a significantly higher risk of developing thrombotic complications and require closer clinical monitoring.

What Does a Lupus Anticoagulant Abs Test Detect?

The Lupus Anticoagulant Abs test panel at Ayzal Lab is designed to detect and confirm the presence of phospholipid-dependent inhibitors through a multi-step testing algorithm. The test detects and evaluates the following clinical parameters and findings:

• Presence of circulating lupus anticoagulant antibodies.
• Prolongation of phospholipid-dependent clotting times.
• Failure to correct prolonged clotting times during a plasma mixing study.
• Correction or shortening of the clotting time upon the addition of excess phospholipids (confirmatory step).
• Dilute Russell’s Viper Venom Time (dRVVT) screen ratio and confirm ratio.
• Modified Lupus Anticoagulant Sensitive aPTT (LA-aPTT) prolongation.
• Silica Clotting Time (SCT) screen and confirm ratios.
• Distinction between factor-specific inhibitors (like Factor VIII inhibitors) and non-specific phospholipid inhibitors.
• Assistance in diagnosing primary Antiphospholipid Syndrome (APS).
• Assistance in diagnosing secondary Antiphospholipid Syndrome associated with SLE.
• Risk assessment for deep vein thrombosis (DVT).
• Risk assessment for pulmonary embolism (PE).
• Evaluation of placental thrombosis risk in pregnant patients.
• Identification of transient antibodies caused by recent viral or bacterial infections.
• Identification of drug-induced lupus anticoagulant antibodies.
• Evaluation of arterial thrombosis risk, including ischemic stroke.
• Assessment of unexplained microvascular thrombosis.
• Determination of the need for long-term therapeutic anticoagulation.
• Baseline coagulation status prior to initiating high-risk therapies.
• Monitoring of autoimmune disease progression and thrombotic risk profile over time.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are essential for effective clinical decision-making and patient peace of mind. The Lupus Anticoagulant Abs test involves complex, multi-stage analytical procedures, including screening, mixing, and confirmatory assays. Typically, the verified test report is completed within 24 to 48 hours of sample collection. Once the results are finalized and approved by our consultant pathologist, patients receive an automated SMS notification. Reports can be accessed securely online through the official Ayzal Lab web portal or mobile application, allowing patients and their physicians to view, download, and print the results immediately from the comfort of their homes.

Lupus Anticoagulant Abs Findings Overview

The diagnosis of lupus anticoagulant is never based on a single test result. It requires a structured panel of assays. The table below outlines the typical parameters evaluated during the testing process at Ayzal Lab:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
dRVVT Screen Ratio	< 1.2 (Normal clotting time)	≥ 1.2 (Prolonged clotting time, suggesting presence of lupus anticoagulant)
dRVVT Confirm Ratio	No significant correction with phospholipid	Significant shortening of clotting time (Confirms phospholipid dependence)
LA-Sensitive aPTT	Within normal reference range (seconds)	Significantly prolonged clotting time
1:1 Mixing Study (aPTT/dRVVT)	Correction of clotting time to normal range	Failure to correct clotting time (Indicates presence of an inhibitor)
Silica Clotting Time (SCT) Ratio	< 1.2 (Normal)	≥ 1.2 (Indicates presence of lupus anticoagulant)
Anti-Cardiolipin Antibodies (IgG/IgM)	Negative / Normal levels	Positive / Elevated levels (Often co-exists with lupus anticoagulant)
Anti-Beta-2 Glycoprotein I (IgG/IgM)	Negative / Normal levels	Positive / Elevated levels (Supports diagnosis of APS)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Lupus Anticoagulant Abs?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and medical technologists specializing in hematology and coagulation disorders.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab adheres to stringent internal and external quality control protocols to ensure maximum accuracy of all coagulation assays.
• Professional Reporting: Our reports are comprehensive, structured, and easy for both clinicians and patients to interpret.
• Modern Diagnostic Approach: We utilize advanced, automated coagulation analyzers that minimize human error and enhance testing precision.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and stress-free experience for every patient.
• Convenient Location: Ayzal Lab is easily accessible, ensuring that patients can undergo diagnostic testing without unnecessary travel hassle.
• Commitment to Accurate Diagnosis: We are dedicated to delivering reliable, evidence-based diagnostic insights that form the foundation of successful patient treatment plans.